Loading provider…
Loading provider…
Hematology & Oncology Physician in Louisville, CO
NPI: 1063617454Primary Practice Location
CENTURA HEALTH-AVISTA ADVENTIST HOSPITAL
100 Health Park Dr, Louisville, CO
Primary Employer
Rocky Mountain Cancer Centers LLP
rockymountaincancercenters.com
HQ Phone
Get MD Ling's Phone Numberphone_androidMobile
Get MD Ling's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 36415Insertion of needle into vein for collection of blood sample | 339 | 1,779 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 301 | 1,553 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 290 | 440 |
| 4 | 80053Blood test, comprehensive group of blood chemicals | 235 | 1,162 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 110 | 480 |
Authors: Xiang, Lian, Du, Tingwan, Zhang, Jingjing, Zhang, Yuanfan, Zhou, Yanqiu, Zhao, Yueying, Zhou, Yong, Ma, Ling
Journal: Eur J Nutr
Publication Date: 2023-09-23
Authors: Xu, Su, Wang, Yijia, Hu, Zhensheng, Ma, Ling, Zhang, Fan, Liu, Pei
Journal: Int Wound J
Publication Date: 2022-11-10
Authors: Qian, Youhui, Su, Qin, Liu, Wenda, Ma, Lilai, Ma, Mengting, Ma, Ling
Journal: Eur J Nutr
Publication Date: 2025-02-22
Lead Sponsor: Mateon Therapeutics
Intervention / Treatment: DRUG: Placebo, DRUG: Fosbretabulin tromethamine
Lead Sponsor: AbbVie
Collaborators: Gynecologic Oncology Group, European Network of Gynaecological Oncological Trial Groups (ENGOT)
Intervention / Treatment: DRUG: Paclitaxel, DRUG: Topotecan, DRUG: Mirvetuximab Soravtansine, DRUG: Pegylated liposomal doxorubicin
Lead Sponsor: pharmaand GmbH
Collaborators: Foundation Medicine
Intervention / Treatment: DRUG: Chemotherapy, DRUG: Rucaparib